RxDoctor Payments Data

Jan Nieves, APRN

Psychiatric/Mental Health · Kearneysville, WVNPI 1528609856

Payments from drug & device makers

$674in general payments, 2019–2025

Across 32 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$267
  • Otsuka America Pharmaceutical, Inc.$113
  • Axsome Therapeutics, Inc.$63
  • Teva Pharmaceuticals USA, Inc.$47
  • AbbVie$47
  • Lundbeck LLC$39
  • plus $98 from 4 others

What the payments were for

  • Food & beverage$66198%
  • Education$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$674 in reported general payments places this provider in the 50th percentile of 142 psychiatric/mental health providers in West Virginia.

See all psychiatric/mental health providers in West Virginia

Medicare billing

Part B allowed, 2024
$80,451
Medicare patients
154
Services billed
1,430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole46$113,432
VraylarCariprazine Hcl27$64,105
TrintellixVortioxetine Hydrobromide57$37,415
Lurasidone Hcl33$27,712
Aripiprazole230$8,116
Lisdexamfetamine Dimesylate28$6,828
Bupropion XlBupropion Hcl198$4,720
Buspirone Hcl189$3,531
Trazodone Hcl118$2,592
Quetiapine Fumarate100$1,897
Venlafaxine Hcl ErVenlafaxine Hcl71$1,798
Lamotrigine93$1,782
Perphenazine11$1,628
Sertraline Hcl203$1,580
Atomoxetine Hcl16$1,573

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$113$113,43246 claims
AbbVieVraylar$47$64,10527 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 142 psychiatric/mental health providers in West Virginia.

Other psychiatric/mental health in Kearneysville

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →